The CB 1 /CB 2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi’s sarcoma cells in vitro Tonia Luca, Giulia Di Benedetto, Mariagrazia Rita Scuderi, Marco Palumbo, Silvia Clementi, Renato Bernardini, Giuseppina Cantarella PII: S0014-2999(09)00515-9 DOI: doi: 10.1016/j.ejphar.2009.06.004 Reference: EJP 65968 To appear in: European Journal of Pharmacology Received date: 10 December 2008 Revised date: 19 May 2009 Accepted date: 3 June 2009 Please cite this article as: Luca, Tonia, Di Benedetto, Giulia, Scuderi, Mariagrazia Rita, Palumbo, Marco, Clementi, Silvia, Bernardini, Renato, Cantarella, Giuseppina, The CB 1 /CB 2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi’s sarcoma cells in vitro, European Journal of Pharmacology (2009), doi: 10.1016/j.ejphar.2009.06.004 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.